Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma

Clinical trial NCT00005976 · COMPLETED

Trial details

NCT number: NCT00005976
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2000-05-01
Primary completion: 2006-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.